ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,601Medicare Part D Prescriptions Filled, Including Refills

Rank: 145 out of 944

$484K Total Retail Price of All Prescriptions

Rank: 227 out of 944

361 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 658 516 1 5
FUROSEMIDE 414 333 2 6
HYDROCODONE-ACETAMINOPHEN 358 230 S3 3 10
LISINOPRIL 358 238 3 3
SIMVASTATIN 314 244 5 1
OMEPRAZOLE 289 189 6 4
ATORVASTATIN CALCIUM 251 190 7 13
LOSARTAN POTASSIUM 232 199 8 16
OXYCODONE-ACETAMINOPHEN 190 56 S2 9 62
METOPROLOL TARTRATE 189 148 10 8
PRAVASTATIN SODIUM 177 120 11 17
WARFARIN SODIUM 174 148 12 7
ALLOPURINOL 174 137 12 22
ZOLPIDEM TARTRATE 161 83 14 25
METFORMIN HCL 160 110 15 12
PANTOPRAZOLE SODIUM 160 124 15 34
LEVOTHYROXINE SODIUM 155 136 17 2
HYDROCHLOROTHIAZIDE 145 102 18 9
CARVEDILOL 140 101 19 30
CLOPIDOGREL 138 94 20 36
GABAPENTIN 131 98 21 18
DIGOXIN 105 88 22 39
SPIRONOLACTONE 104 88 23 44
TRAMADOL HCL 102 72 24 21
GLIPIZIDE ER 91 58 25 89
OXYCODONE HCL-ACETAMINOPHEN 90 15 S2 26 127
MIRTAZAPINE 83 74 27 35
JANUVIA 83 60 27 81
ATENOLOL 81 70 29 11
METOPROLOL SUCCINATE 80 60 30 14
PREDNISONE 80 45 30 32
PROAIR HFA 79 45 32 56
TRIAMTERENE-HCTZ 75 68 33 33
MORPHINE SULFATE ER 75 29 S2 33 80
CYCLOBENZAPRINE HCL 75 26 R 33 86
METHADONE HCL 74 0 S2 36 134
DONEPEZIL HCL 73 67 37 24
POTASSIUM CHLORIDE 72 55 38 15
RANITIDINE HCL 68 54 39 42
DOXAZOSIN MESYLATE 68 63 39 60
PLAVIX 68 56 39 55
ALENDRONATE SODIUM 68 68 39 20
LYRICA 64 35 43 114
NORTRIPTYLINE HCL 64 64 43 204
BENAZEPRIL HCL 64 44 43 66
CLONIDINE HCL 63 42 46 67
LANTUS SOLOSTAR 61 44 47 61
SERTRALINE HCL 58 40 48 23
OXYCONTIN 58 11 S2 48 92
CARISOPRODOL 56 32 R 50 240
PEN NEEDLE 56 46 50 100
COLCRYS 55 53 52 222
TAMSULOSIN HCL 53 32 53 27
LANTUS 53 33 53 46
NEXIUM 50 32 55 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.